Independent Advisor Alliance’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
2,885
+17
+0.6% +$6.3K 0.03% 431
2026
Q1
$840K Buy
2,868
+29
+1% +$9.53K 0.01% 910
2025
Q4
$995K Sell
2,839
-106
-4% -$35.8K 0.02% 471
2025
Q3
$952K Sell
2,945
-562
-16% -$175K 0.02% 453
2025
Q2
$1.36M Sell
3,507
-45
-1% -$18.1K 0.04% 351
2025
Q1
$1.54M Sell
3,552
-438
-11% -$176K 0.05% 291
2024
Q4
$1.47M Sell
3,990
-4,511
-53% -$1.89M 0.02% 607
2024
Q3
$4.42M Sell
8,501
-512
-6% -$274K 0.16% 111
2024
Q2
$4.88M Sell
9,013
-199
-2% -$105K 0.17% 103
2024
Q1
$4.78M Buy
9,212
+294
+3% +$146K 0.17% 105
2023
Q4
$4.21M Buy
8,918
+40
+0.5% +$18.5K 0.15% 116
2023
Q3
$3.87M Sell
8,878
-227
-2% -$103K 0.17% 107
2023
Q2
$4.05M Sell
9,105
-219
-2% -$101K 0.18% 104
2023
Q1
$4.29M Sell
9,324
-2,235
-19% -$1.06M 0.21% 97
2022
Q4
$5.93K Buy
11,559
+40
+0.3% +$20.3K ﹤0.01% 185
2022
Q3
$5.23M Buy
11,519
+1,803
+19% +$863K 0.31% 77
2022
Q2
$4.69M Sell
9,716
-104
-1% -$51.5K 0.26% 89
2022
Q1
$4.82M Buy
9,820
+7,347
+297% +$3.36M 0.23% 89
2021
Q4
$1.15M Sell
2,473
-181
-7% -$76.1K 0.06% 260
2021
Q3
$989K Buy
2,654
+148
+6% +$56.2K 0.06% 269
2021
Q2
$957K Sell
2,506
-676
-21% -$258K 0.05% 288
2021
Q1
$1.14M Buy
3,182
+12
+0.4% +$3.86K 0.07% 233
2020
Q4
$1.02M Buy
3,170
+1,120
+55% +$344K 0.07% 212
2020
Q3
$550K Sell
2,050
-207
-9% -$55.7K 0.04% 269
2020
Q2
$593K Buy
2,257
+127
+6% +$33.9K 0.06% 234
2020
Q1
$484K Buy
2,130
+46
+2% +$12.5K 0.07% 218
2019
Q4
$629K Sell
2,084
-372
-15% -$102K 0.03% 480
2019
Q3
$590K Sell
2,456
-2,042
-45% -$559K 0.07% 230
2019
Q2
$1.27M Sell
4,498
-36
-0.8% -$9.83K 0.18% 112
2019
Q1
$1.3M Buy
4,534
+2,144
+90% +$620K 0.18% 114
2018
Q4
$628K Buy
2,390
+336
+16% +$92.4K 0.11% 170
2018
Q3
$478K Sell
2,054
-1,814
-47% -$471K 0.09% 198
2018
Q2
$870K Sell
3,868
-302
-7% -$69.9K 0.18% 131
2018
Q1
$918K Buy
4,170
+304
+8% +$71.4K 0.2% 120
2017
Q4
$896K Buy
3,866
+1,442
+59% +$307K 0.2% 127
2017
Q3
$462K Buy
2,424
+188
+8% +$35.8K 0.13% 157
2017
Q2
$430K Sell
2,236
-76
-3% -$13.7K 0.14% 159
2017
Q1
$381K Buy
+2,312
New +$368K 0.06% 264

Other funds holding ELV

Independent Advisor Alliance's ELV Position: Q2 2026 in Review

Independent Advisor Alliance increased its Elevance Health (ELV) stake by 0.59% in Q2 2026, buying an estimated $6.3K and bringing the position to 2,885 shares worth $1.12M. The position accounts for 0.03% of the portfolio, ranked #431.

Independent Advisor Alliance first reported a position in ELV in Q1 2017 and has held it in 38 quarters since. The position peaked at $5.23M in Q3 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Independent Advisor Alliance held 2,885 shares of Elevance Health worth $1.12M as of Q2 2026.
  • Independent Advisor Alliance bought 17 Elevance Health shares in Q2 2026, an estimated $6.3K.
  • Elevance Health made up 0.03% of Independent Advisor Alliance's portfolio in Q2 2026, its #431 holding.
  • Independent Advisor Alliance first reported a position in Elevance Health in Q1 2017 and has held it in 38 quarters since.
  • Independent Advisor Alliance's Elevance Health position peaked at $5.23M in Q3 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Independent Advisor Alliance's 13F filing for Q2 2026, filed 12 Aug 2026.